Skip to content

Depression: all studies

Page 317 of 1,034: studies 3,161 to 3,170 of 10,336, newest first. Back to the depression overview

Research

Mindfulness‐based cognitive therapy: an efficacious community‐based group intervention for depression and anxiety in a sample of cancer patients

The Medical Journal of Australia September 1, 2010 Greg Sharplin, Simeon B W Jones, Barbara Hancock et al. 48 citations

OBJECTIVE: To assess the impact of an 8-week structured mindfulness-based cognitive therapy (MBCT) program on individuals experiencing distress as a consequence of cancer. DESIGN, SETTING AND PARTICIPANTS: Prospective study of 16 participants with a history of cancer and five carers of people with cancer recruited from August 2008 to February 2009 through calls to the Cancer Council South...

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Archives of General Psychiatry August 1, 2010 Nancy Diazgranados, Lobna Ibrahim, Nancy E. Brutsché et al. 969 citations

CONTEXT: Existing therapies for bipolar depression have a considerable lag of onset of action. Pharmacological strategies that produce rapid antidepressant effects-for instance, within a few hours or days-would have an enormous impact on patient care and public health. OBJECTIVE: To determine whether an N-methyl-D-aspartate-receptor antagonist produces rapid antidepressant effects in subjects...

Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

The Journal of Clinical Psychiatry July 13, 2010 Nancy Diazgranados, Lobna Ibrahim, Nancy E. Brutsché et al. 563 citations

OBJECTIVE: Suicidal ideation is a medical emergency, especially when severe. Little research has been done on pharmacologic interventions that could address this problem. Ketamine, an N-methyl-D-asparate antagonist, has been reported to have antidepressant effects within hours. We examined the effects of a single dose of ketamine on suicidal ideation in subjects with treatment-resistant major...

Polysomnographic and subjective profiles of sleep continuity before and after mindfulness-based cognitive therapy in partially remitted depression.

Psychosomatic Medicine July 2010 Willoughby B. Britton, Patricia L. Haynes, Keith W Fridel et al.

To examine whether mindfulness meditation (MM) was associated with changes in objectively measured polysomnographic (PSG) sleep profiles and to relate changes in PSG sleep to subjectively reported changes in sleep and depression within the context of a randomized controlled trial. Previous studies have indicated that mindfulness and other forms of meditation training are associated with...

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Journal of Palliative Medicine July 2010 Scott A Irwin, Alana Iglewicz

Depression is prevalent and undertreated in patients receiving hospice care. Standard antidepressants do not work rapidly or often enough to benefit most of these patients. Here, two cases are reported in which a single oral dose of ketamine provided rapid and moderately sustained symptom relief for both depression and anxiety. In addition, no adverse effects were noted. Further investigation...

Experiential Avoidance, Mindfulness and Depression in Spinal Cord Injuries: A Preliminary Study

The Australian Journal of Rehabilitation Counselling May 1, 2010 Timothy C. Skinner, Terri Roberton, Garry T. Allison et al.

Abstract: This preliminary study sought to explore the link between depression, experiential avoidance and mindfulness in people with a spinal cord injury (SCI). We surveyed patients listed on the SCI database at Royal Perth Hospital who had experienced an injury over the last 10 years. Respondents (62) completed a questionnaire including the depression subscale of the Depression Anxiety Stress...